Can available mathematical models predict serum digoxin levels in Thai patients?

• Main Authors: J. Jiratham-Opas, R. Kanjanavanit, W. Wongcharoen, B. Punyawudho, P. Arunmanakul, A. Amaritakomol, P. Topaiboon, S. Gunaparn, A. Phrommintikul
• Format: Journal
• Published: 2018
• Subjects: Medicine; Pharmacology, Toxicology and Pharmaceutics
• Online Access: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85041023177&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/58899
• Institution: Chiang Mai University

© 2018 John Wiley & Sons Ltd What is known and objective: Digoxin is commonly prescribed for heart failure patients with reduced ejection fraction (HFrEF) and patients with atrial fibrillation (AF). Due to digoxin's narrow therapeutic range, monitoring the serum digoxin concentration (SDC...